WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Join the AAN today!
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (47)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Svenningsson, P.
Right arrow Articles by Fredholm, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Svenningsson, P.
Right arrow Articles by Fredholm, B. B.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CAFFEINE

 Previous Article  |  Next Article 

The Journal of Neuroscience, May 15, 1999, 19(10):4011-4022

The Stimulatory Action and the Development of Tolerance to Caffeine Is Associated with Alterations in Gene Expression in Specific Brain Regions

Per Svenningsson, George G. Nomikos, and Bertil B. Fredholm

Section of Molecular Neuropharmacology, Department of Physiology and Pharmacology, Karolinska Institutet, 17177 Stockholm, Sweden

We sought neurochemical correlates to the stimulatory action of caffeine in rats and to adaptations during development of tolerance. Acute intraperitoneal injections of caffeine (7.5 mg/kg) increased locomotion and NGFI-A mRNA, a marker of neuronal activity, in the hippocampal area CA1, but decreased NGFI-A mRNA in rostral striatum and nucleus accumbens. Rats that received caffeine (0.3 gm/l) in their drinking water for 14 d developed tolerance to the stimulatory effect of a challenge with caffeine (7.5 mg/kg) and responded with a less pronounced decrease of NGFI-A mRNA in rostral striatum and nucleus accumbens. Metabolism of caffeine to its active metabolites was increased in tolerant animals, but the total level of active metabolites in brain was not significantly altered. Thus, there are changes in caffeine metabolism after long-term caffeine treatment, but they cannot explain development of tolerance.

Caffeine-tolerant animals had downregulated levels of adenosine A2A receptors and the corresponding mRNA in rostral parts of striatum, but an increased expression of adenosine A1 receptor mRNA in the lateral amygdala. No changes in mesencephalic tyrosine hydroxylase mRNA were found in caffeine-tolerant rats.

Thus, we have identified neuronal pathways that are regulated by adenosine A1 and/or A2A receptors and are targets for the stimulatory action of caffeine. Furthermore, adaptive changes in gene expression in these brain areas were associated with the development of locomotor tolerance to caffeine.

Key words: caffeine; methylxanthines; adenosine receptors; immediate early genes; striatum; drug tolerance; locomotion; in situ hybridization


Copyright © 1999 Society for Neuroscience  0270-6474/99/19104011-12$05.00/0


This article has been cited by other articles:


Home page
J. Neurosci.Home page
F. Ciruela, V. Casado, R. J. Rodrigues, R. Lujan, J. Burgueno, M. Canals, J. Borycz, N. Rebola, S. R. Goldberg, J. Mallol, et al.
Presynaptic Control of Striatal Glutamatergic Neurotransmission by Adenosine A1-A2A Receptor Heteromers
J. Neurosci., February 15, 2006; 26(7): 2080 - 2087.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
D. E. Fedele, N. Gouder, M. Guttinger, L. Gabernet, L. Scheurer, T. Rulicke, F. Crestani, and D. Boison
Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation
Brain, October 1, 2005; 128(10): 2383 - 2395.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. B. Fredholm and P. Svenningsson
Adenosine-dopamine interactions: Development of a concept and some comments on therapeutic possibilities
Neurology, December 9, 2003; 61(90116): S5 - 9.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. S. Kim and R. D. Palmiter
Adenosine receptor blockade reverses hypophagia and enhances locomotor activity of dopamine-deficient mice
PNAS, February 4, 2003; 100(3): 1346 - 1351.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
E. Bastia and M. A. Schwarzschild
DARPP Chocolate: A Caffeinated Morsel of Striatal Signaling
Sci. Signal., January 14, 2003; 2003(165): pe2 - pe2.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
B. B. Fredholm, A. P. IJzerman, K. A. Jacobson, K.-N. Klotz, and J. Linden
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Pharmacol. Rev., December 1, 2001; 53(4): 527 - 552.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Johansson, L. Halldner, T. V. Dunwiddie, S. A. Masino, W. Poelchen, L. Gimenez-Llort, R. M. Escorihuela, A. Fernandez-Teruel, Z. Wiesenfeld-Hallin, X.-J. Xu, et al.
Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor
PNAS, July 19, 2001; (2001) 161292398.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Johansson, L. Halldner, T. V. Dunwiddie, S. A. Masino, W. Poelchen, L. Gimenez-Llort, R. M. Escorihuela, A. Fernandez-Teruel, Z. Wiesenfeld-Hallin, X.-J. Xu, et al.
Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor
PNAS, July 31, 2001; 98(16): 9407 - 9412.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-